Home » Authors » Anette Breindl

Articles by Anette Breindl

Applications Are Everywhere For This Year's Science Prizes

Oct. 11, 2007

By Anette Breindl

Applications Are Everywhere For This Year's Science Prizes

Oct. 11, 2007

By Anette Breindl

Targeting Cellular MicroRNA Can Flush HIV Out Of Hiding

Oct. 8, 2007

By Anette Breindl

Targeting Cellular MicroRNA Can Flush HIV Out Of Hiding

Oct. 8, 2007

By Anette Breindl

Targeting One Channel Through Another For Specific Anesthesia

Oct. 4, 2007

By Anette Breindl

Targeting One Channel Through Another For Specific Anesthesia

Oct. 4, 2007

By Anette Breindl

Study Shows Delivery Method Key To Whether RNAi Is Toxic

Oct. 1, 2007

By Anette Breindl

Study Shows Delivery Method Key To Whether RNAi Is Toxic

Oct. 1, 2007

By Anette Breindl

New Targets Good, Combined Markets Better To Attack NTDs

Sep. 26, 2007

By Anette Breindl

New Targets Good, Combined Markets Better To Attack NTDs

Sep. 26, 2007

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
Gensci-134: a long-acting growth hormone receptor agonist fusion protein
BioWorld Science
Gensci-134 (Genescience Pharmaceuticals Co. Ltd.) is a growth hormone receptor (GHR) agonist fusion protein that mimics the biological activity of growth hormone...